CYP2D6 is a key drug-metabolizing enzyme that breaks down many medications – including some that affect sleep (e.g., certain antidepressants, antipsychotics, or opioids). Genetic variants (poor, intermediate, extensive, ultrarapid metabolizer) can alter drug efficacy and side effects. However, a direct effect of CYP2D6 on natural sleep-wake regulation is not established. Most associations with sleep issues are indirect and medication-mediated. Without concurrent drug use, a CYP2D6 genetic test is not informative for sleep problems. Be cautious of overinterpretation: consumer tests often list many genes, but clinical relevance for sleep is low. For sleep disorders, medical evaluation should come first.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-ba2aef95ce9fe6300b11f347